Akorn, Inc. (AKRX) was a big mover last session, as its shares rose over 6% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company since Oct 31, as the stock is now down over 15%.
In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep an eye on this stock going forward.
Akorn currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.
Other well-performing medical stocks include Mallinckrodt public limited company (MNK), Mylan, Inc. (MYL) and KaloBios Pharmaceuticals, Inc. (KBIO). All three carry a Zacks Rank #1.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment